These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16382891)

  • 21. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
    Assmus B; Tonn T; Seeger FH; Yoon CH; Leistner D; Klotsche J; Schächinger V; Seifried E; Zeiher AM; Dimmeler S
    J Am Coll Cardiol; 2010 Mar; 55(13):1385-94. PubMed ID: 20338501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
    Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
    Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous adventitial delivery of allogeneic bone marrow-derived stem cells via infarct-related artery improves long-term ventricular function in acute myocardial infarction.
    Medicetty S; Wiktor D; Lehman N; Raber A; Popovic ZB; Deans R; Ting AE; Penn MS
    Cell Transplant; 2012; 21(6):1109-20. PubMed ID: 22004910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Liu B; Duan CY; Luo CF; Ou CW; Sun K; Wu ZY; Huang H; Cheng CF; Li YP; Chen MS
    Int J Cardiol; 2014 Dec; 177(3):764-70. PubMed ID: 25465825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function].
    Suárez de Lezo J; Herrera C; Pan M; Romero M; Pavlovic D; Segura J; Sánchez J; Ojeda S; Torres A
    Rev Esp Cardiol; 2007 Apr; 60(4):357-65. PubMed ID: 17521544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction--MI3 Trial.
    Nair V; Madan H; Sofat S; Ganguli P; Jacob MJ; Datta R; Bharadwaj P; Sarkar RS; Pandit AJ; Nityanand S; Goel PK; Garg N; Gambhir S; George PV; Chandy S; Mathews V; George OK; Talwar KK; Bahl A; Marwah N; Bhatacharya A; Bhargava B; Airan B; Mohanty S; Patel CD; Sharma A; Bhatnagar S; Mondal A; Jose J; Srivastava A;
    Indian J Med Res; 2015 Aug; 142(2):165-74. PubMed ID: 26354213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis.
    Hristov M; Heussen N; Schober A; Weber C
    J Cell Mol Med; 2006; 10(3):727-33. PubMed ID: 16989732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
    Drexler H; Meyer GP; Wollert KC
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation.
    Grajek S; Popiel M; Gil L; Breborowicz P; Lesiak M; Czepczyński R; Sawiński K; Straburzyńska-Migaj E; Araszkiewicz A; Czyz A; Kozłowska-Skrzypczak M; Komarnicki M
    Eur Heart J; 2010 Mar; 31(6):691-702. PubMed ID: 20022872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials.
    Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ
    Int J Cardiol; 2009 Aug; 136(2):178-85. PubMed ID: 18644638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.
    Kang HJ; Kim HS; Zhang SY; Park KW; Cho HJ; Koo BK; Kim YJ; Soo Lee D; Sohn DW; Han KS; Oh BH; Lee MM; Park YB
    Lancet; 2004 Mar; 363(9411):751-6. PubMed ID: 15016484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.
    Erbs S; Linke A; Schächinger V; Assmus B; Thiele H; Diederich KW; Hoffmann C; Dimmeler S; Tonn T; Hambrecht R; Zeiher AM; Schuler G
    Circulation; 2007 Jul; 116(4):366-74. PubMed ID: 17620510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
    N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: current status of myocardial regeneration: new cell sources and new strategies.
    Rangappa S; Makkar R; Forrester J
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):338-43. PubMed ID: 21098418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials.
    de Jong R; Houtgraaf JH; Samiei S; Boersma E; Duckers HJ
    Circ Cardiovasc Interv; 2014 Apr; 7(2):156-67. PubMed ID: 24668227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of autologous bone marrow derived CD34+ stem cells on the left ventricular function following myocardial infarction].
    Balogh L; Czuriga I; Hunyadi J; Galuska L; Kristóf E; Edes I
    Orv Hetil; 2007 Feb; 148(6):243-9. PubMed ID: 17344174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.